Lack of Efficacy of Hydergine in Patients with Alzheimer's Disease

ALZHEIMER'S disease is the most common dementing illness and may be the fourth leading cause of death in the United States. It severely affects about 1.4 million Americans, and this number is predicted to increase fivefold in the next half century. 1 2 3 4 The current direct and indirect annual...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 1990-08, Vol.323 (7), p.445-448
Hauptverfasser:	Thompson, Troy L, Filley, Christopher M, Mitchell, Wayne D, Culig, Kathleen M, LoVerde, Mary, Byyny, Richard L
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Alzheimer Disease - drug therapy Alzheimer's disease Bioavailability Biological Availability Capsules Clinical trials Clinical Trials as Topic Cognitive ability Consent Dementia Dihydroergotoxine - administration & dosage Dihydroergotoxine - therapeutic use Double-Blind Method Electroencephalography FDA approval Female Geriatrics Humans Intelligence Intelligence Tests Male Medical imaging Memory Mental disorders Middle Aged Neurodegenerative diseases Patients Psychiatric Status Rating Scales Psychiatry Wechsler Scales
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!